Skip to main content
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1973 Nov;52(11):2941–2951. doi: 10.1172/JCI107491

Metabolic Effects of Plasmin Digests of Human Growth Hormone in the Rat and Man

John B Mills 1,2,3,4, Charles R Reagan 1,2,3,4, Daniel Rudman 1,2,3,4, Jack L Kostyo 1,2,3,4, P Zachariah 1,2,3,4, Alfred E Wilhelmi 1,2,3,4
PMCID: PMC302563  PMID: 4270645

Abstract

As a first step in our study of structure-function relationships among primate and non-primate growth hormones, human growth hormone (hGH) was subjected to the limited digestive activity of human plasmin. The lyophilized whole digest, containing less than 2% of unchanged hormone, had an average of 2.3 new amino-terminal groups per mole. The digest had the same potency as the native hormone (a) in causing weight gain in hypophysectomized rats; (b) in stimulating somatomedin production in hypophysectomized rats; (c) in stimulating upake of [3H]leucine into isolated diaphragm of hypophysectomized rats; (d) in accelerating transport of [14C]α-aminoisobutyric acid into isolated diaphragm of hypophysectomized rats; (e) in stimulating uptake of [3-0-methyl-14C]glucose by isolated adipose tissue of hypophysectomized rats; (f) in accelerating conversion of [14C]glucose to 14CO2 by isolated epididymal adipose tissue of hypophysectomized rats. The digest also caused glucosuria in partially pancreatectomized rats treated with dexamethasone.

These metabolic actions of plasmin-digested hGH in the array of animal tests were confirmed by comparable effects elicited in 11 human subjects (nine pituitary-deficient children and adolescents and two nondeficient adults). A single injection of the plasmin digest caused an increase in plasma free fatty acids and a fall in plasma amino acids. Seven daily injections caused positive balances of nitrogen, phosphorous, sodium, and potassium, gain in body weight, and in two of three subjects impairment of glucose tolerance. The potency of the plasmin digest in producing these metabolic effects in man was comparable to that of native hGH.

Thus, 2-3 bonds in the hGH molecule can be cleaved by plasmin without impairing the hormone's growthpromoting, anabolic, diabetogenic, and adipokinetic actions for rat and man.

Full text

PDF
2945

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bates R. W., Garrison M. M. Studies in 80 per cent pancreatectomized rats of the synergistic interaction of growth hormone, ACTH and the glucocorticoids (corticosterone, cortisol, prednisone and dexamethasone) as diabetogenic agents. Endocrinology. 1971 Jun;88(6):1429–1436. doi: 10.1210/endo-88-6-1429. [DOI] [PubMed] [Google Scholar]
  2. Cheever E. V., Lewis U. J. Estimation of the molecular weights of the multiple components of growth hormone and prolactin. Endocrinology. 1969 Sep;85(3):465–473. doi: 10.1210/endo-85-3-465. [DOI] [PubMed] [Google Scholar]
  3. DOLE V. P. A relation between non-esterified fatty acids in plasma and the metabolism of glucose. J Clin Invest. 1956 Feb;35(2):150–154. doi: 10.1172/JCI103259. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Daughaday W. H., Hall K., Raben M. S., Salmon W. D., Jr, van den Brande J. L., van Wyk J. J. Somatomedin: proposed designation for sulphation factor. Nature. 1972 Jan 14;235(5333):107–107. doi: 10.1038/235107a0. [DOI] [PubMed] [Google Scholar]
  5. Daughaday W. H., Reeder C. Synchronous activation of DNA synthesis in hypophysectomized rat cartilage by growth hormone. J Lab Clin Med. 1966 Sep;68(3):357–368. [PubMed] [Google Scholar]
  6. ELSAIR J., VAIREL E., GERBEAUX S., DARTOIS A. M., ROYER P. EFFETS DE L'HORMONE DE CROISSANCE DANS LE NANISME HYPOTHALAMO-HYPOPHYSAIRE. II. ETUDE DES ACTIONS M'ETABOLIQUES DE NOUVELLES PR'EPARATIONS D'HORMONE DE CROISSANCE BOVINE PARTIELLEMENT HYDROLYS'EE. Rev Fr Etud Clin Biol. 1964 Jun-Jul;9:614–624. [PubMed] [Google Scholar]
  7. Ellis S., Nuenke J. M., Grindeland R. E. Identity between the growth hormone degrading activity of the pituitary gland and plasmin. Endocrinology. 1968 Nov;83(5):1029–1042. doi: 10.1210/endo-83-5-1029. [DOI] [PubMed] [Google Scholar]
  8. FORSHAM P. H., LI C. H., DIRAIMONDO V. C., KOLB F. O., MITCHELL D., NEWMAN S. Nitrogen retention in man produced by chymotrypsin digests of bovine somatotropin. Metabolism. 1958 Nov;7(6):762–764. [PubMed] [Google Scholar]
  9. Free C. A., Sonenberg M. Separation and properties of multiple components of bovine growth hormone. J Biol Chem. 1966 Nov 10;241(21):5076–5082. [PubMed] [Google Scholar]
  10. GOODMAN H. M. IN VITRO ACTIONS OF GROWTH HORMONE ON GLUCOSE METABOLISM IN ADIPOSE TISSUE. Endocrinology. 1965 Feb;76:216–225. doi: 10.1210/endo-76-2-216. [DOI] [PubMed] [Google Scholar]
  11. KOSTYO J. L. SEPARATION OF THE EFFECTS OF GROWTH HORMONE ON MUSCLE AMINO ACID TRANSPORT AND PROTEIN SYNTHESIS. Endocrinology. 1964 Jul;75:113–119. doi: 10.1210/endo-75-1-113. [DOI] [PubMed] [Google Scholar]
  12. LEWIS U. J. Enzymatic transformations of growth hormone and prolactin. J Biol Chem. 1962 Oct;237:3141–3145. [PubMed] [Google Scholar]
  13. LEWIS U. J. FACTORS THAT AFFECT THE FRAGMENTATION OF GROWTH HORMONE AND PROLACTIN BY HYPOPHYSIAL PROTEINASES. J Biol Chem. 1963 Oct;238:3330–3335. [PubMed] [Google Scholar]
  14. LI C. H., PAPKOFF H., FONSS-BECH P., CONDLIFFE P. G. Action of chymotrypsin on hypophyseal growth hormone. J Biol Chem. 1956 Jan;218(1):41–52. [PubMed] [Google Scholar]
  15. Mills J. B., Ashworth R. B., Wilhelmi A. E., Hartree A. S. Improved method for the extraction and purification of human growth hormone. J Clin Endocrinol Metab. 1969 Nov;29(11):1456–1459. doi: 10.1210/jcem-29-11-1456. [DOI] [PubMed] [Google Scholar]
  16. Mills J. B., Howard S. C., Scapa S., Wilhelmi A. E. Cyanogen bromide cleavage and partial amino acid sequence of porcine growth hormone. J Biol Chem. 1970 Jul 10;245(13):3407–3415. [PubMed] [Google Scholar]
  17. Nadler A. C., Sonenberg M., New M. I., Free C. A. Growth hormone activity in man with components of tryptic digests of bovine growth hormone. Metabolism. 1967 Sep;16(9):830–845. doi: 10.1016/0026-0495(67)90185-0. [DOI] [PubMed] [Google Scholar]
  18. Nutting D. F., Kostyo J. L., Mills J. B., Wilhelmi A. E. Dissociation of some of the biological activities of porcine and human growth hormones by cyanogen bromide cleavage. Endocrinology. 1972 May;90(5):1202–1213. doi: 10.1210/endo-90-5-1202. [DOI] [PubMed] [Google Scholar]
  19. ORNSTEIN L. DISC ELECTROPHORESIS. I. BACKGROUND AND THEORY. Ann N Y Acad Sci. 1964 Dec 28;121:321–349. doi: 10.1111/j.1749-6632.1964.tb14207.x. [DOI] [PubMed] [Google Scholar]
  20. Parlow A. F., Wilhelmi A. E., Reichert L. E., Jr Further studies on the fractionation of human pituitary glands. Endocrinology. 1965 Dec;77(6):1126–1134. doi: 10.1210/endo-77-6-1126. [DOI] [PubMed] [Google Scholar]
  21. REUSSER F. ELECTROPHORESIS AND IMMUNOLOGY OF PURIFIED BOVINE GROWTH HORMONE. Arch Biochem Biophys. 1964 Jul 20;106:410–414. doi: 10.1016/0003-9861(64)90208-5. [DOI] [PubMed] [Google Scholar]
  22. Rudman D., Chyatte S. B., Gerron G. G., O'Beirne I., Barlow J. Hyper-responsiveness of patients with limb-girdle dystrophy to human growth hormone. J Clin Endocrinol Metab. 1972 Aug;35(2):256–260. doi: 10.1210/jcem-35-2-256. [DOI] [PubMed] [Google Scholar]
  23. Rudman D., Chyatte S. B., Patterson J. H., Gerron G. G., O'Beirne I., Barlow J., Ahmann P., Jordan A., Mosteller R. C. Observations on the responsiveness of human subjects to human growth hormone. Effects of endogenous growth hormone deficiency and myotinic dystrophy. J Clin Invest. 1971 Sep;50(9):1941–1949. doi: 10.1172/JCI106686. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Rudman D., Chyatte S. B., Patterson J. H., Gerron G. G., O'Beirne I., Barlow J., Jordan A., Shavin J. S. Metabolic effects of human growth hormone and of estrogens in boys with Duchenne muscular dystrophy. J Clin Invest. 1972 May;51(5):1118–1124. doi: 10.1172/JCI106904. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Sonenberg M., Free C. A., Dellacha J. M., Bonadonna G., Haymowitz A., Nadler A. C. The metabolic effects in man of bovine growth hormone digested with trypsin. Metabolism. 1965 Nov;14(11):1189–1213. doi: 10.1016/0026-0495(65)90090-9. [DOI] [PubMed] [Google Scholar]
  26. Sonenberg M., Kikutani M., Free C. A., Nadler A. C., Dellacha J. M. Chemical and biological characterization of clinically active tryptic digests of bovine growth hormone. Ann N Y Acad Sci. 1968 Feb 5;148(2):532–558. doi: 10.1111/j.1749-6632.1968.tb20373.x. [DOI] [PubMed] [Google Scholar]
  27. Yamasaki N., Kangawa K., Kobayashi S., Kikutani M., Sonenberg M. Amino acid sequence of a biologically active fragment of bovine growth hormone. J Biol Chem. 1972 Jun 25;247(12):3874–3880. [PubMed] [Google Scholar]
  28. Yamasaki N., Kikutani M., Sonenberg M. Peptides of a biologically active tryptic digest of bovine growth hormone. Biochemistry. 1970 Mar 3;9(5):1107–1114. doi: 10.1021/bi00807a009. [DOI] [PubMed] [Google Scholar]
  29. Yde H. A simplified technique for the determination of growth hormone dependent sulfation factor, using intact animals. Acta Endocrinol (Copenh) 1968 Apr;57(4):557–564. doi: 10.1530/acta.0.0570557. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES